Coinspeaker MRNA Stock Fell 16.36% as Moderna Faces Serious Competition in Coronavirus Vaccine RaceModerna (MRNA) stock price fell yesterday. This happened as both Merck and Novavax are set to go into COVID-19 vaccine trials.MRNA Stock Fell 16.36% as Moderna Faces Serious Competition in Coronavirus Vaccine Race